Innovent Biologics, Inc. (HKG:1801)
Hong Kong
· Delayed Price · Currency is HKD
85.70
+3.95 (4.83%)
Mar 10, 2026, 11:54 AM HKT
Innovent Biologics Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 141,851 | 59,956 | 69,333 | 51,403 | 70,547 | 115,098 | |
| Market Cap Growth | 130.91% | -13.53% | 34.88% | -27.14% | -38.71% | 243.36% | |
| Enterprise Value | 135,101 | 54,283 | 63,850 | 44,899 | 59,352 | 109,367 | |
| Last Close Price | 81.75 | 36.60 | 42.75 | 33.50 | 48.25 | 82.05 | |
| PS Ratio | 11.33 | 5.98 | 10.14 | 9.98 | 13.46 | 25.21 | |
| PB Ratio | 8.98 | 4.30 | 5.02 | 4.24 | 5.56 | 11.04 | |
| P/TBV Ratio | 9.93 | 4.40 | 5.04 | 4.25 | 5.57 | 11.04 | |
| P/FCF Ratio | 89.42 | 175.32 | - | - | - | - | |
| P/OCF Ratio | 71.27 | 43.78 | 425.78 | - | - | - | |
| EV/Sales Ratio | 10.79 | 5.41 | 9.34 | 8.72 | 11.33 | 23.96 | |
| EV/EBITDA Ratio | 97.52 | 2126.28 | - | - | - | - | |
| EV/FCF Ratio | 85.16 | 158.73 | - | - | - | - | |
| Debt / Equity Ratio | 0.23 | 0.22 | 0.29 | 0.30 | 0.24 | 0.14 | |
| Debt / EBITDA Ratio | 2.54 | 50.93 | - | - | - | - | |
| Debt / FCF Ratio | 2.33 | 8.81 | - | - | - | - | |
| Net Debt / Equity Ratio | -0.43 | -0.38 | -0.59 | -0.55 | -0.63 | -0.79 | |
| Net Debt / EBITDA Ratio | -4.73 | -210.62 | 5.70 | 2.06 | 2.57 | 14.13 | |
| Net Debt / FCF Ratio | -4.26 | -15.72 | 7.56 | 2.11 | 2.11 | 8.68 | |
| Asset Turnover | 0.52 | 0.45 | 0.33 | 0.27 | 0.30 | 0.40 | |
| Inventory Turnover | 2.94 | 2.69 | 1.51 | 1.00 | 1.19 | 1.45 | |
| Quick Ratio | 2.25 | 2.08 | 2.68 | 2.78 | 3.27 | 5.85 | |
| Current Ratio | 2.61 | 2.35 | 3.00 | 3.29 | 3.79 | 6.37 | |
| Return on Equity (ROE) | 8.43% | -0.74% | -8.84% | -20.70% | -28.56% | -14.75% | |
| Return on Assets (ROA) | 2.65% | -0.82% | -5.12% | -11.54% | -12.04% | -3.65% | |
| Return on Capital Employed (ROCE) | 5.00% | -1.60% | -9.70% | -22.20% | -20.50% | -5.40% | |
| Earnings Yield | 0.87% | -0.17% | -1.63% | -4.79% | -4.75% | -1.03% | |
| FCF Yield | 1.12% | 0.57% | -1.54% | -6.19% | -5.38% | -0.82% | |
| Buyback Yield / Dilution | -3.74% | -4.35% | -4.67% | -2.37% | -7.27% | -15.23% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.